Frontiers in Immunology (Aug 2022)

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer and cytotoxic T-cell-mediated pathology: Case report

  • Haruna Akanuma,
  • Takahiro Iizuka,
  • Dan Abe,
  • Kenji Yoshida,
  • Nozomu Matsuda,
  • Kotaro Sugimoto,
  • Yuko Hashimoto,
  • Kazuaki Kanai

DOI
https://doi.org/10.3389/fimmu.2022.952868
Journal volume & issue
Vol. 13

Abstract

Read online

Anti-N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is caused by a reversible inhibition of ion channel actions by autoantibodies and is associated with a relatively good prognosis. Pathological findings of NMDAR encephalitis usually do not show neurophagorous nodules, but rare or mild inflammatory infiltration. We report a patient of small cell lung cancer (SCLC)-related paraneoplastic encephalitis with NMDAR antibodies, a cytotoxic T-cell-mediated pathology of the brain, and a rapid clinical course. This case highlights that the neuropathological diversity of NMDAR encephalitis may be even broader than previously thought and that NMDAR antibodies may also be found in various pathological conditions with a vigorous immune response.

Keywords